SelectQuote, Inc. (SLQT)

Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT). Investors who purchased SelectQuote shares are encouraged to obtain additional information and assist the investigation.

    

The investigation concerns whether SelectQuote and certain of its officers and/or directors have violated federal securities laws.

 

On February 7, 2022, SelectQuote reported its financial results for the second quarter of fiscal year 2022.  Among other items, SelectQuote reported a quarterly loss of $0.84 per share and a 45% year-over-year revenue decline.  The Company’s Chief Executive Officer Tim Danker attributed the shortfall to “unexpected challenges” in SelectQuote’s Medicare Advantage business.  In addition, SelectQuote updated its 2022 guidance to forecast a net loss of $255 million to $236 million.  On this news, SelectQuote’s stock price fell $2.99 per share, or 45.79%, to close at $3.54 per share on February 8, 2022.

If you are aware of any facts relating to this investigation or purchased SelectQuote shares, you can assist this investigation.  You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.